Myeloperoxidase as an Imaging Biomarker
Latest article in Radiology 111593; Published online March 21, 2012, talks of use of myeloperoxidase as an Imaging Biomarker and Therapeutic Target in Demyelinating Diseases. According to them, MPO could represent a promising therapeutic target, as well as an imaging biomarker, for demyelinating diseases and potentially for other diseases in which MPO is implicated.
Myeloperoxidase as an Imaging Biomarker
![]()
Reviewed by Sumer Sethi
on
Thursday, March 22, 2012
Rating:
Sumer Sethi
Unique blend of academic excellence and entrepreneurship, heading leading firms in India- Teleradiology Providers, pioneering company providing teleradiology services and DAMS (Delhi Academy of Medical Sciences) Premier test preparation institute in India for MD/MS/MCI preparation. He has also been an invited faculty member at various conferences, including Teleradiology in IRIA 2008 and 2011, Hospital Build Middle East, Congress of the Brain Tumor Radiology in Neuro-oncology Society. Dr. Sethi is Editor-in-Chief of Internet Journal of Radiology. He has a keen interest in Web 2.0 technologies and in maintaining his famous radiology blog, which has been featured in multiple international journals.
No comments:
Post a Comment